‌

US Patent 10442865 Methods of use of anti-CD123 antibodies and antigen-binding fragments thereof

Patent 10442865 was granted and assigned to Immunogen, Inc. on October, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Yelena Kovtun0

Daniel J. Tavares0

Lingyun Rui0

Thomas Chittenden0

Date of Patent

October 15, 2019

0

Patent Application Number

159577570

Date Filed

April 19, 2018

0

Patent Citations

US Patent 10077313 Anti-CD123 antibodies and conjugates and derivatives thereof

Patent Citations Received

US Patent 11278628 Pharmaceutical formulations and methods of use thereof

US Patent 11332535 Anti-CD123 antibodies and conjugates and derivatives thereof

US Patent 10875925 Anti-CD123 antibodies and conjugates and derivatives thereof

Patent Primary Examiner

Bridget E Bunner

0

Patent abstract

The present invention generally relates to antibodies, antigen-binding fragments thereof, polypeptides, and immunoconjugates that bind to CD123 antigen (the a chain of the interleukine 3 receptor, or IL-3Rα). The present invention also relates to methods of using such CD123-binding molecules for diagnosing and treating diseases, such as B-cell malignancies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10442865 Methods of use of anti-CD123 antibodies and antigen-binding fragments thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool